<DOC>
	<DOCNO>NCT01153009</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety tolerability vortioxetine , daily ( QD ) , compare placebo adult major depressive disorder .</brief_summary>
	<brief_title>Safety Efficacy Vortioxetine ( Lu AA21004 ) Adults With Major Depressive Disorder</brief_title>
	<detailed_description>The drug test study call Vortioxetine . Vortioxetine test treat depression adult major depressive disorder ( MDD ) . This study look MDD relief people take vary dosage vortioxetine . The study enrol 614 patient . Participants randomly assign ( chance , like flip coin ) one four treatment groups—which remain undisclosed patient study doctor study ( unless urgent medical need ) : - Vortioxetine 15 mg - Vortioxetine 20 mg - Duloxetine 60 mg - Placebo ( dummy inactive capsule ) - capsule look like study drug active ingredient . All participant ask take one capsule time day throughout study . This multi-center trial conduct United States . The overall time participate study 13 week . Participants make 9 visit clinic , contact telephone 4 week last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>1 . Man woman suffer major depressive episode ( MDE ) recurrent primary diagnosis accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition , Text Revision ( DSMIVTR ) criterion ( classification code 296.3x ) confirm Structured Clinical Interview DSM Disorders ( SCID ) . 2 . The report duration current MDE least 3 month . 3 . Has Montgomery Åsberg Depression Rating Scale ( MADRS ) total score 26 great Screening Baseline Visits . 4 . Has Clinical Global Impression Severity Illness ( CGIS ) score 4 great Screening Baseline Visits . 1 . Has previously participate Lu AA21004 clinical study . 2 . Has 1 follow : 1 . Any current psychiatric disorder major depressive disorder ( MDD ) define DSMIVTR ( assessed SCID ) . 2 . Current past history : manic hypomanic episode , schizophrenia psychotic disorder , include major depression psychotic feature , mental retardation , organic mental disorder , mental disorder due general medical condition define DSMIVTR . 3 . Diagnosis substance abuse dependence ( except nicotine caffeine ) define DSMIVTR sustain full remission least 2 year prior screen ( subject must also negative urine drug screen prior Baseline ) . 4 . Presence history clinically significant neurological disorder ( include epilepsy ) . 5 . Neurodegenerative disorder ( Alzheimer disease , Parkinson disease , multiple sclerosis , Huntington disease , etc ) . 6 . Any Axis II disorder might compromise study . 3 . The current depressive symptom consider investigator resistant 2 adequate antidepressant treatment least 6 week duration . Has 1 laboratory value outside normal range , base blood urine sample take Screening Visit , consider investigator clinically significant . 4 . Has thyroid stimulate hormone value outside normal range Screening Visit deem clinically significant investigator . 5 . Has clinically significant abnormal vital sign determine investigator . 6 . Has abnormal electrocardiogram determine central reader confirm clinically significant investigator . 7 . Has alanine aminotransferase , aspartate aminotransferase total bilirubin level great 1.5 time upper limit normal . 8 . Has previous history cancer remission le 5 year prior first dose study medication . This criterion include patient basal cell Stage I squamous cell carcinoma skin . 9 . Has disease take medication , opinion investigator , could interfere assessment safety , tolerability , efficacy . 10 . Has know history currently increase intraocular pressure risk acute narrowangle glaucoma . 11 . Has clinically significant unstable illness , example , hepatic impairment renal insufficiency , cardiovascular , pulmonary , gastrointestinal , endocrine , neurological , rheumatologic , immunologic , infectious , skin subcutaneous tissue disorder , metabolic disturbance . The follow also consider unstable due potential impact assessment MDD response : pain disorder , chronic fatigue syndrome , fibromyalgia , obstructive sleep apnea . 12 . Has significant risk suicide accord investigator 's opinion score great equal 5 item 10 ( suicidal thought ) Montgomery Åsberg Depression Rating Scale make suicide attempt previous 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Depression</keyword>
	<keyword>Melancholia</keyword>
	<keyword>Drug Therapy</keyword>
</DOC>